Todos Medical Statistics
Total Valuation
Todos Medical has a market cap or net worth of 332,397.
| Market Cap | 332,397 |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Todos Medical has 3.32 billion shares outstanding.
| Current Share Class | 3.32B |
| Shares Outstanding | 3.32B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +6.61% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.25 |
| Interest Coverage | -0.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.91% |
| Return on Invested Capital (ROIC) | -85.17% |
| Return on Capital Employed (ROCE) | -72,050.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.89 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9,900.00% in the last 52 weeks. The beta is 9.42, so Todos Medical's price volatility has been higher than the market average.
| Beta (5Y) | 9.42 |
| 52-Week Price Change | +9,900.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 99.61 |
| Average Volume (20 Days) | 168,213 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.08 |
Income Statement
In the last 12 months, Todos Medical had revenue of 10.75 million and -38.77 million in losses. Loss per share was -0.04.
| Revenue | 10.75M |
| Gross Profit | 4.48M |
| Operating Income | -11.53M |
| Pretax Income | -38.83M |
| Net Income | -38.77M |
| EBITDA | -10.74M |
| EBIT | -11.53M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 57,000 in cash and 35.87 million in debt, giving a net cash position of -35.82 million or -0.01 per share.
| Cash & Cash Equivalents | 57,000 |
| Total Debt | 35.87M |
| Net Cash | -35.82M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -30.64M |
| Book Value Per Share | -0.02 |
| Working Capital | -11.62M |
Cash Flow
In the last 12 months, operating cash flow was -3.80 million and capital expenditures -1.94 million, giving a free cash flow of -5.74 million.
| Operating Cash Flow | -3.80M |
| Capital Expenditures | -1.94M |
| Free Cash Flow | -5.74M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 41.66% |
| Operating Margin | -107.25% |
| Pretax Margin | -361.22% |
| Profit Margin | n/a |
| EBITDA Margin | -99.89% |
| EBIT Margin | -107.25% |
| FCF Margin | n/a |
Dividends & Yields
Todos Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.78% |
| Shareholder Yield | -85.78% |
| Earnings Yield | -11,663.16% |
| FCF Yield | -1,725.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Todos Medical has an Altman Z-Score of -13.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.35 |
| Piotroski F-Score | 2 |